| The Pharmaceutical Journal |
||
|
PDF* 75K |
|
PI insurance
|
The SocietyNeed for effective representative bodyFrom Mr G. M. Hill, MRPharmS In his reply to letters from David Coleman and Mel Smith last week (PJ, 30 November, p781) on the Royal Pharmaceutical Society's response to MLX 285 (patient information leaflets), Stephen Lutener made it clear that the Society's regulatory role compromised its ability to represent the interests of its members on this issue. The Society was therefore unable to participate in the joint response and (yet again) the profession of pharmacy fails to present a united front. In my view, no further proof is needed to show that the proposed dual role for the Society will always mean regulation before representation. Unless we act now and try to create an effective representative body that operates alongside, but independently of a modern regulatory body, the vision of pharmacy in the future will remain just that. Graham Hill |
|
|
Send your letter to The Editor |
Previous Topic (Packaging) |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal